CRA is a proud sponsor of the event.
Elina Koustoumpardi is a speaker during the presentation titled “EU Commission Revision of 102 Guidelines: Impact on Pricing and Rebates.”
- Update on the implications of draft Article 102 guidelines: examining the notion of competition on the merits
- Review of authority approach: recent excessive pricing decisions, challenges in assessing and enforcing theories of harm based on excessive pricing
- Court of Justice ruling in Google and Apple cases and the implications for the pharmaceutical industry
- Implications and practical actions in light of new guidance for the industry
For more information on this event, click here.
